PMID- 23637281 OWN - NLM STAT- MEDLINE DCOM- 20131219 LR - 20211021 IS - 1943-0264 (Electronic) IS - 1943-0264 (Linking) VI - 5 IP - 5 DP - 2013 May 1 TI - The role of MuSK in synapse formation and neuromuscular disease. PG - a009167 LID - 10.1101/cshperspect.a009167 [doi] LID - a009167 AB - Muscle-specific kinase (MuSK) is essential for each step in neuromuscular synapse formation. Before innervation, MuSK initiates postsynaptic differentiation, priming the muscle for synapse formation. Approaching motor axons recognize the primed, or prepatterned, region of muscle, causing motor axons to stop growing and differentiate into specialized nerve terminals. MuSK controls presynaptic differentiation by causing the clustering of Lrp4, which functions as a direct retrograde signal for presynaptic differentiation. Developing synapses are stabilized by neuronal Agrin, which is released by motor nerve terminals and binds to Lrp4, a member of the low-density lipoprotein receptor family, stimulating further association between Lrp4 and MuSK and increasing MuSK kinase activity. In addition, MuSK phosphorylation is stimulated by an inside-out ligand, docking protein-7 (Dok-7), which is recruited to tyrosine-phosphorylated MuSK and increases MuSK kinase activity. Mutations in MuSK and in genes that function in the MuSK signaling pathway, including Dok-7, cause congenital myasthenia, and autoantibodies to MuSK, Lrp4, and acetylcholine receptors are responsible for myasthenia gravis. FAU - Burden, Steven J AU - Burden SJ AD - Molecular Neurobiology Program, Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular Medicine, NYU Medical School, New York, NY 10016, USA. FAU - Yumoto, Norihiro AU - Yumoto N FAU - Zhang, Wei AU - Zhang W LA - eng PT - Journal Article PT - Review DEP - 20130501 PL - United States TA - Cold Spring Harb Perspect Biol JT - Cold Spring Harbor perspectives in biology JID - 101513680 RN - 0 (Agrin) RN - 0 (LDL-Receptor Related Proteins) RN - 0 (LRP4 protein, human) RN - 0 (Receptors, Cholinergic) RN - EC 2.7.10.1 (MUSK protein, human) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) SB - IM MH - Agrin/metabolism/physiology MH - Cell Differentiation MH - Humans MH - LDL-Receptor Related Proteins/chemistry/immunology/physiology MH - Models, Biological MH - Muscles/cytology/innervation/pathology MH - Myasthenia Gravis/*genetics/pathology MH - Myasthenic Syndromes, Congenital/*genetics/pathology MH - Protein Structure, Tertiary MH - Receptor Protein-Tyrosine Kinases/chemistry/immunology/*physiology MH - Receptors, Cholinergic/chemistry/immunology/*physiology MH - Synapses/*metabolism PMC - PMC3632064 EDAT- 2013/05/03 06:00 MHDA- 2013/12/20 06:00 PMCR- 2015/05/01 CRDT- 2013/05/03 06:00 PHST- 2013/05/03 06:00 [entrez] PHST- 2013/05/03 06:00 [pubmed] PHST- 2013/12/20 06:00 [medline] PHST- 2015/05/01 00:00 [pmc-release] AID - 5/5/a009167 [pii] AID - a009167 [pii] AID - 10.1101/cshperspect.a009167 [doi] PST - epublish SO - Cold Spring Harb Perspect Biol. 2013 May 1;5(5):a009167. doi: 10.1101/cshperspect.a009167.